Coronary heart disease with diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 25-75 years old; 2. Coronary angiography shows that the coronary artery and the main branch have more than = 50% of the stenosis and implanted drug-eluting stent (DES); 3. Diagnosed diabetes patients; 4. Can accept and cooperate with more than half a year of follow-up; 5. Informed consent form approved by the Ethics Committee.
Exclusion criteria
Exclusion criteria: 1. Significant aortic regurgitation, aortic aneurysm, and dissection aneurysm; 2. Coronary artery spasm or severe coronary aneurysm; 3. Symptomatic congestive heart failure; 4. Heart valve disease, congenital heart disease, cardiomyopathy; 5. Cerebral hemorrhage within half a year, hemorrhagic disease or clear bleeding tendency; 6. Lower extremity infection, phlebitis, severe varicose veins, deep vein thrombosis; 7. Progressive malignancy or serious disease with poor prognosis; 8. Systolic blood pressure =180mmHg, or diastolic blood pressure =110mmHg when randomly grouped; 9. Severe arrhythmia affecting ECP therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in myocardial IMR values between the two groups after six months of stenting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in cardiac function (heart ultrasound) between the two groups after the stent;Differences in activity tolerance index between two groups of patients after stent operation;Differences in blood glucose between the two groups after six months of stenting;Differences in blood lipids between two groups of patients after six months of stenting; | — |
Countries
China
Contacts
The Eighth Affiliated Hospital, Sun Yat-sen University